These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2522069)

  • 1. [Extensive erosive hemorrhagic lesions in psoriasis plaques caused by methotrexate poisoning].
    Rytter M; Haustein UF
    Dermatol Monatsschr; 1989; 175(1):55-8. PubMed ID: 2522069
    [No Abstract]   [Full Text] [Related]  

  • 2. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous ulceration caused by methotrexate.
    Kazlow DW; Federgrun D; Kurtin S; Lebwohl MG
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl Case Reports):S197-8. PubMed ID: 12894123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulcerations due to methotrexate toxicity in a psoriasis patient.
    Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
    An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate in psoriasis: do we need to give a test dose?
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012 Jan; 103(1):1-4. PubMed ID: 22440152
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate-induced papular eruption following treatment of psoriasis.
    Mebazaa A; Kenani N; Denguezli M; Ben Salem C; Ziadi S; Sriha B; Belajouza C; Nouira R
    Ann Pharmacother; 2008 Jan; 42(1):138-41. PubMed ID: 18094347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
    Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
    Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous drug eruption in a patient with psoriasis after a test dose of methotrexate.
    Sako EY; Famenini S; Wu JJ
    J Am Acad Dermatol; 2013 Nov; 69(5):e264-e265. PubMed ID: 24124857
    [No Abstract]   [Full Text] [Related]  

  • 11. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflamed psoriatic plaques: drug toxicity or disease exacerbation?
    Jindal N; Arora K; Jindal P; Jain VK; Ghosh S
    Indian J Pharmacol; 2013; 45(4):410-1. PubMed ID: 24014924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker.
    Delyon J; Ortonne N; Benayoun E; Moroch J; Wolkenstein P; Sbidian E; Chosidow O
    J Am Acad Dermatol; 2015 Sep; 73(3):484-90. PubMed ID: 26190242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eventration caused by methotrexate in a psoriatic patient.
    Conte H; Ezzedine K; Jouary T; Hubiche T; Taieb A; Milpied B
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):76-7. PubMed ID: 19453786
    [No Abstract]   [Full Text] [Related]  

  • 15. Local reaction after subcutaneous injection of methotrexate: uncommon side effect.
    Priego-Recio CM; Camacho-Martínez FM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):523-4. PubMed ID: 25546179
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucocutaneous ulcerations secondary to methotrexate.
    Warner J; Brown A; Whitmore SE; Cowan DA
    Cutis; 2008 May; 81(5):413-6. PubMed ID: 18543592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erosion of psoriatic plaques: an early sign of methotrexate toxicity.
    Pearce HP; Wilson BB
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 2):835-8. PubMed ID: 8912599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate toxicity presenting as cutaneous ulcerations on psoriatic plaques.
    Koçak AY; Koçak O; Aslan F; Tektaş M
    Cutan Ocul Toxicol; 2013 Oct; 32(4):333-5. PubMed ID: 23537374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.